We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology research at DovePress

Providing a quality, professional service to authors wherever they are in the world

GO TO SUBMISSION SITE

Are you searching for where to publish your next article?

Increase your impact as a researcher by publishing with Dove Medical Press, a pioneer open access publisher in the scientific, technical, and medical sciences. Experience thorough yet timely peer-review of your research and publish online within just a few weeks.

Find the journal that best compliments your research and become our next published author.
Cancer Management and Research

Publishes cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. 64,000+ monthly downloads | 3.602 Impact Factor

OncoTargets and Therapy

Publishes the molecular diagnosis and targeted molecular or precision therapy for all types of cancer, exploring new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients. 50,000+ monthly downloads | 4.345 Impact Factor

Blood and Lymphatic Cancer: Targets and Therapy

Publishes blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient. Every article is PubMed and PubMed Central indexed to extend the reach and readership of your research.

Breast Cancer: Targets and Therapy

Publishes basic and translational research, clinical trials and treatment for breast cancer. Treatment studies should incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients. 11,000+ monthly downloads | 5.088 Impact Factor

Journal of Hepatocellular Carcinoma

Publishes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of hepatocellular carcinoma, spanning from basic laboratory research through to clinical and translational research. 10,000+ monthly downloads | 4.962 Impact Factor

Lung Cancer: Targets and Therapy

Publishes lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. Q1 rank in Oncology from SJR | 6.5 CiteScore

Oncolytic Virotherapy

Publishes original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer. Every article is PubMed and PubMed Central indexed to extend the reach and readership of your research.

Do you wish to know about the research and integrity checks we make on all submitted papers?

We have listed the pre-peer review, post-peer review, and post-acceptance inspections that are used to validate your research.

Are you interested in publishing your next article with DovePress?

Authors are encouraged to send an abstract to obtain a view from the Editor about the suitability of their paper. The Editor will perform a pre-submission check based on the subject matter versus the aims and scope of the journal and advise if it is suitable for submission.

Explore More

Discover our #ResearchWithImpact article collection

hand holding purple ribbon

From portfolio to progress, Taylor & Francis lets the research speak for itself. Explore our Oncology collection, featuring key areas within our portfolio covering the drive for progress, screening & diagnosis, and genetics & evolution.

SHARE THIS PAGE

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.